Ligand Pharmaceuticals Announces Second Quarter Results
- Details
- Category: Financial
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) today announced financial results for the three months ended June 30, 2007 and provided a business update. The Company sold its commercial oncology product line in October 2006 and sold the AVINZA(R) product line in February 2007.
Santhera and Takeda Extend European Marketing Collaboration for SNT-MC17
- Details
- Category: Clinical Trials
Santhera Pharmaceuticals (SWX: SANN, "Santhera"), a Swiss specialty pharmaceutical company with a focus on neuromuscular diseases, and Takeda Pharmaceutical Company Limited (TSE: 4502, "Takeda"), today announced they have extended their existing commercialization partnership for SNT-MC17 (INN: idebenone) in the European Union and Switzerland to cover the compound's second indication of Duchenne Muscular Dystrophy (DMD). SNT-MC17 is currently in a Phase II clinical trial in Europe for DMD. Results of this trial are expected to be released later this year.
Availability on line of the sanofi-aventis half-year financial report for 2007
- Details
- Category: Sanofi
![sanofi-aventis sanofi-aventis](http://www.worldpharmanews.com/images/stories/logo/sanofi-avenits.gif)
Merck Announces Fourth Quarter 2007 Dividend
- Details
- Category: Merck
![Merck & Co., Inc. Merck & Co., Inc.](http://www.worldpharmanews.com/images/stories/logo/merk.gif)
Key business with prescription medicines continues to boost growth at Boehringer Ingelheim
- Details
- Category: Boehringer Ingelheim
![Boehringer Ingelheim Boehringer Ingelheim](http://www.worldpharmanews.com/images/stories/logo/boehringeringelheim.gif)
New Spiriva® Respimat® inhaler completes European approval process for COPD
- Details
- Category: Boehringer Ingelheim
![Boehringer Ingelheim Boehringer Ingelheim](http://www.worldpharmanews.com/images/stories/logo/boehringeringelheim.gif)
Boehringer Ingelheim announces first international head-to-head trial of Aptivus®
- Details
- Category: Boehringer Ingelheim
![Boehringer Ingelheim Boehringer Ingelheim](http://www.worldpharmanews.com/images/stories/logo/boehringeringelheim.gif)
More Pharma News ...
- Recommendation of Approval for the Merz Botulinum Neurotoxin Typ A in European Countries
- The U.S. Launch of Neupro® for the Treatment of Early-Stage Parkinson's Disease
- Novartis Completes Divestment of Medical Nutrition Business
- Sandoz Receives Positive EU Opinion for Approval of epoetin alfa biosimilar
- Merck Provides Update on Status of Supplemental Biologics License Applications (sBLA) for GARDASIL®
- UK Body Recommends Pfizer's Champix (varenicline) for Smokers
- JANUVIA Approved in the European Union for the Treatment of Type 2 Diabetes